Clinical Trial Update: Effect of One Year Elexacaftor-tezacaftor-ivacaftor Treatment

View source ↗

Summary

A clinical trial update reports the completion of a one-year treatment with elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Cystic Fibrosis | Status: COMPLETED